FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142431231> ?p ?o ?g. }

• W3142431231 abstract "Background The association between atopic dermatitis (AD) and allergic contact dermatitis (ACD) is controversial. Objective To analyze the prevalence, reaction strength, and trends of the most commonly positive and relevant allergens in patients with AD referred for patch testing. Methods This was a retrospective analysis of 38,482 patients from the North American Contact Dermatitis Group, 2001 to 2016. Results Most adults (56.0%) and children (52.8%) with a history of AD had a final diagnosis of ACD. Adults (66.5% vs 65.6%; χ2, P = .1459) and children (61.4% vs 62.3%, P = .7074) with or without a history of AD had similar proportions of one or more allergic patch test reactions. Adults with a history of AD had a greater number of allergic patch test positive reactions than those without it (2.0 ± 2.4 vs 1.9 ± 2.3; t test, P < .0001), whereas children did not (1.5 ± 1.8 vs 1.4 ± 1.6; P = .3839). Nickel sulfate, methylisothiazolinone, formaldehyde, fragrance mix I, sodium gold thiosulfate, and thimerosal were the most common allergens in adults and children with a history of AD. In multivariable logistic regression models, adults with versus without a history of AD had increased odds of reacting to 10 of the top 25 North American Contact Dermatitis Group screening allergens. Most allergens had similar strengths of reaction in adults or children with and without a history of AD or a current AD diagnosis; cobalt, fragrance mix I, and propylene glycol had weaker reactions. In multivariable logistic regression, adults with versus without an AD history had increased odds of relevance for 10 of the 25 most currently relevant allergens, whereas children with an AD history did not have increased relevance for any specific allergens. Conclusions Most patients referred for patch testing with AD history had a final diagnosis of ACD. Patients with AD history had a similar likelihood of having a positive patch test reaction as those without an AD history. Adults with an AD history had a higher number of positive patch test reactions. The association between atopic dermatitis (AD) and allergic contact dermatitis (ACD) is controversial. To analyze the prevalence, reaction strength, and trends of the most commonly positive and relevant allergens in patients with AD referred for patch testing. This was a retrospective analysis of 38,482 patients from the North American Contact Dermatitis Group, 2001 to 2016. Most adults (56.0%) and children (52.8%) with a history of AD had a final diagnosis of ACD. Adults (66.5% vs 65.6%; χ2, P = .1459) and children (61.4% vs 62.3%, P = .7074) with or without a history of AD had similar proportions of one or more allergic patch test reactions. Adults with a history of AD had a greater number of allergic patch test positive reactions than those without it (2.0 ± 2.4 vs 1.9 ± 2.3; t test, P < .0001), whereas children did not (1.5 ± 1.8 vs 1.4 ± 1.6; P = .3839). Nickel sulfate, methylisothiazolinone, formaldehyde, fragrance mix I, sodium gold thiosulfate, and thimerosal were the most common allergens in adults and children with a history of AD. In multivariable logistic regression models, adults with versus without a history of AD had increased odds of reacting to 10 of the top 25 North American Contact Dermatitis Group screening allergens. Most allergens had similar strengths of reaction in adults or children with and without a history of AD or a current AD diagnosis; cobalt, fragrance mix I, and propylene glycol had weaker reactions. In multivariable logistic regression, adults with versus without an AD history had increased odds of relevance for 10 of the 25 most currently relevant allergens, whereas children with an AD history did not have increased relevance for any specific allergens. Most patients referred for patch testing with AD history had a final diagnosis of ACD. Patients with AD history had a similar likelihood of having a positive patch test reaction as those without an AD history. Adults with an AD history had a higher number of positive patch test reactions." @default.
• W3142431231 created "2021-04-13" @default.
• W3142431231 creator A5001692630 @default.
• W3142431231 creator A5005058453 @default.
• W3142431231 creator A5006454345 @default.
• W3142431231 creator A5011094833 @default.
• W3142431231 creator A5011739266 @default.
• W3142431231 creator A5019286021 @default.
• W3142431231 creator A5020605192 @default.
• W3142431231 creator A5030289968 @default.
• W3142431231 creator A5031933716 @default.
• W3142431231 creator A5035988449 @default.
• W3142431231 creator A5037982488 @default.
• W3142431231 creator A5052928814 @default.
• W3142431231 creator A5058911983 @default.
• W3142431231 creator A5063751569 @default.
• W3142431231 creator A5068691017 @default.
• W3142431231 creator A5076874635 @default.
• W3142431231 creator A5080239016 @default.
• W3142431231 date "2021-03-01" @default.
• W3142431231 modified "2023-09-26" @default.
• W3142431231 title "Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016" @default.
• W3142431231 cites W1528693268 @default.
• W3142431231 cites W1896294707 @default.
• W3142431231 cites W1996528206 @default.
• W3142431231 cites W2004818381 @default.
• W3142431231 cites W2007084697 @default.
• W3142431231 cites W2048532989 @default.
• W3142431231 cites W2053258947 @default.
• W3142431231 cites W2060621834 @default.
• W3142431231 cites W2072538818 @default.
• W3142431231 cites W2083612050 @default.
• W3142431231 cites W2088495555 @default.
• W3142431231 cites W2106192211 @default.
• W3142431231 cites W2134538843 @default.
• W3142431231 cites W2142289238 @default.
• W3142431231 cites W2146302565 @default.
• W3142431231 cites W2532220783 @default.
• W3142431231 cites W2604631534 @default.
• W3142431231 cites W2606268778 @default.
• W3142431231 cites W2611107905 @default.
• W3142431231 cites W2616033307 @default.
• W3142431231 cites W2757040992 @default.
• W3142431231 cites W2781752850 @default.
• W3142431231 cites W2797320652 @default.
• W3142431231 cites W2807330238 @default.
• W3142431231 cites W2883568898 @default.
• W3142431231 cites W2884188896 @default.
• W3142431231 cites W2895762929 @default.
• W3142431231 cites W2901519773 @default.
• W3142431231 cites W2908530488 @default.
• W3142431231 cites W2909910516 @default.
• W3142431231 cites W2946322933 @default.
• W3142431231 cites W2979421755 @default.
• W3142431231 doi "https://doi.org/10.1016/j.jaip.2021.03.028" @default.
• W3142431231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33781959" @default.
• W3142431231 hasPublicationYear "2021" @default.
• W3142431231 type Work @default.
• W3142431231 sameAs 3142431231 @default.
• W3142431231 citedByCount "7" @default.
• W3142431231 countsByYear W31424312312021 @default.
• W3142431231 countsByYear W31424312312022 @default.
• W3142431231 countsByYear W31424312312023 @default.
• W3142431231 crossrefType "journal-article" @default.
• W3142431231 hasAuthorship W3142431231A5001692630 @default.
• W3142431231 hasAuthorship W3142431231A5005058453 @default.
• W3142431231 hasAuthorship W3142431231A5006454345 @default.
• W3142431231 hasAuthorship W3142431231A5011094833 @default.
• W3142431231 hasAuthorship W3142431231A5011739266 @default.
• W3142431231 hasAuthorship W3142431231A5019286021 @default.
• W3142431231 hasAuthorship W3142431231A5020605192 @default.
• W3142431231 hasAuthorship W3142431231A5030289968 @default.
• W3142431231 hasAuthorship W3142431231A5031933716 @default.
• W3142431231 hasAuthorship W3142431231A5035988449 @default.
• W3142431231 hasAuthorship W3142431231A5037982488 @default.
• W3142431231 hasAuthorship W3142431231A5052928814 @default.
• W3142431231 hasAuthorship W3142431231A5058911983 @default.
• W3142431231 hasAuthorship W3142431231A5063751569 @default.
• W3142431231 hasAuthorship W3142431231A5068691017 @default.
• W3142431231 hasAuthorship W3142431231A5076874635 @default.
• W3142431231 hasAuthorship W3142431231A5080239016 @default.
• W3142431231 hasConcept C126322002 @default.
• W3142431231 hasConcept C140764562 @default.
• W3142431231 hasConcept C151956035 @default.
• W3142431231 hasConcept C156957248 @default.
• W3142431231 hasConcept C16005928 @default.
• W3142431231 hasConcept C203014093 @default.
• W3142431231 hasConcept C207480886 @default.
• W3142431231 hasConcept C2776056826 @default.
• W3142431231 hasConcept C2778091633 @default.
• W3142431231 hasConcept C2778329239 @default.
• W3142431231 hasConcept C2780510475 @default.
• W3142431231 hasConcept C2781179581 @default.
• W3142431231 hasConcept C2909485332 @default.
• W3142431231 hasConcept C71924100 @default.
• W3142431231 hasConceptScore W3142431231C126322002 @default.
• W3142431231 hasConceptScore W3142431231C140764562 @default.
• W3142431231 hasConceptScore W3142431231C151956035 @default.
• W3142431231 hasConceptScore W3142431231C156957248 @default.
• W3142431231 hasConceptScore W3142431231C16005928 @default.

• next